More about

Interstitial Lung Disease

News
June 28, 2023
2 min read
Save

Female patients with Sjögren’s syndrome more like to exhibit eye symptoms than males

There are several differences in the symptoms reported among male and female patients with primary Sjögren’s syndrome, according to data published in the Journal of Clinical Rheumatology.

News
June 21, 2023
4 min read
Save

Ziritaxestat fails to improve lung function in patients with idiopathic pulmonary fibrosis

WASHINGTON — In patients with idiopathic pulmonary fibrosis, yearly lung function decline rates did not improve with two different dosages of ziritaxestat, according to an American Thoracic Society International Conference presentation.

News
May 23, 2023
3 min read
Save

High levels of air pollution linked to ILD prevalence, acute exacerbations, death

WASHINGTON — Exposure to air pollutants at high levels contributed to interstitial lung disease incidence, acute exacerbations and death, according to an abstract presented at the American Thoracic Society International Conference.

News
April 28, 2023
4 min read
Save

Hunting for the ‘elusive’ Sjögren’s diagnosis: How multiple specialties can improve delays

In rheumatology, there is no shortage of conditions that are difficult to diagnose, with diseases like fibromyalgia and systemic lupus erythematosus sometimes taking years before being officially identified — leading to adverse outcomes.

News
April 25, 2023
3 min read
Save

Certain elevated biomarkers aid in diagnosis of systemic sclerosis-related ILD

For diagnosing systemic sclerosis-related ILD, Krebs von den Lungen-6, surfactant protein-D and interleukin-8 in blood/bronchoalveolar lavage fluid samples were found to be “reliable biomarkers,” according to results published in Thorax.

News
April 19, 2023
2 min read
Save

Composite serum biomarker may improve identification of interstitial lung disease in SSc

A composite biomarker index could improve the risk stratification and diagnosis of interstitial lung disease in patients with systemic sclerosis, according to data published in Arthritis & Rheumatology.

News
April 18, 2023
2 min read
Save

Patients with pulmonary arterial hypertension with CTD exhibit 59% 10-year survival rate

Patients with pulmonary arterial hypertension associated with connective tissue disease demonstrate a “poor” 10-year rate of 59.9%, according to data published in Rheumatology.

News
March 29, 2023
2 min read
Save

Lung abnormalities persist in some patients 2 years after COVID-19 infection

Thirty-nine percent of patients who suffered a COVID-19 infection had interstitial lung abnormalities 2 years following the illness, according to study results published in Radiology.

News
March 20, 2023
2 min read
Save

Q&A: Treating pulmonary hypertension-ILD with high-dose inhaled treprostinil

Inhaled treprostinil is used to treat pulmonary hypertension with interstitial lung disease, and a study recently found that higher doses led to better clinical outcomes than a lower dose or placebo.

News
February 10, 2023
3 min read
Save

Suspected ILD among patients with interstitial lung abnormalities linked to high mortality

About half of patients with interstitial lung abnormalities had suspected interstitial lung disease, with these patients having greater symptoms and more unfavorable clinical outcomes, according to study results.

View more